Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics and FMT for ESBL-E/CPE Eradication
NCT02472600Phase 2Unknown
- Start
- Feb 2016
- Primary completion
- Nov 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of Fecal Microbiota Transplantation Capsule in Enterobacteriaceae colonization (2 arms). Primary endpoint: Intestinal carriage of ESBL-E / CRE. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT02472600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472600.